Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-20-074349
Date:2020-06-16
Issuer: CASI PHARMACEUTICALS, INC. (CASI)
Original Submission Date:

Reporting Person:

SALISBURY FRANKLIN CARY JR
CASI PHARMACEUTICALS, INC.
9620 MEDICAL CENTER DR. SUITE 300 ROCKVILLE, MD 20850

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.63 2020-06-16 deemed execution date A 68,800 (a) 2030-06-16 common stock 68,800 $2.63 68,800 direct
Footnotes
IDfootnote
f1 stock option award will vest ratably quarterly to the end of the year.
WhaleWisdom Logo

Elevate your investments